CovidVax show full list

Linear DNA

Takis Biotech + Applied DNA Sciences + Evvivax + Rottapharm Biotech
(Italy + USA)
vaccine type: DNA-based
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)



started February 3 2021

with 160 healthy volunteers aged 18+

trial location: Italy

» clinical trial details

Feb 08Takis' DNA vaccine could start its clinical trials in March after being approved by Italy's national drug regulator last week (by
Feb 03Takis and Rottapharm Biotech announced the authorization of Phase 1/2 clinical trial of their vaccine by AIFA (by
Apr 15AppliedDNA is planning the execution of its cGMP to support human trials in Autumn (by
Animal Testing updates (pre-clinical trials)
start date: April 2020
developed 5 vaccine candidates
Jul 17AppliedDNA and Takis report positive preclinical results from their DNA vaccine candidates (by
Jun 08AppliedDNA and Takis preclinical study on their vaccine is progressing as planned (by
May 04AppliedDNA and Takis first injection of their vaccine have neutralized antibodies in test animals (by
Apr 15AppliedDNA ships LinearDNA vaccine candidates to begin pre-clinical animal testing (by
Apr 02AppliedDNA added a 5th vaccine candidate to enhance probability of success (by
Mar 17Pre-clinical trial results of the AppliedDNA/Takis vaccine will be available in April (by
early development updates
currently no early development info

Feb 07Applied DNA Sciences and Takis Biotech expand existing agreement to Covid-19 vaccine (by
Jan 27Takis Biotech and Evvivax start a partnership to develop a DNA-based vaccine (by

contact | about | ©2020 project